FDA To Hold Next-Generation Sequencing Workshops In November
This article was originally published in The Gray Sheet
Executive Summary
The agency will host two public workshops on evaluating next-generation sequencing diagnostics on Nov. 12-13, and is asking for feedback on analytical performance evaluations of NGS diagnostics and use of databases to establish clinical relevance of human genetic variants for the tests.